Tekmira Pharmaceuticals Corporation
TSX : TKM

Tekmira Pharmaceuticals Corporation

September 08, 2009 17:09 ET

Tekmira Pharmaceuticals to Webcast Presentation at the Rodman & Renshaw Global Investment Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 8, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that the Company's President and Chief Executive Officer, Dr. Mark Murray, will present a corporate overview at the Rodman & Renshaw Annual Global Investment Conference on Thursday, September 10, 2009 at 4:05 pm ET at the New York Palace Hotel in New York City. A live webcast of the presentation will be available and can be accessed on the Company's website, www.tekmirapharm.com.

Dr. Murray will also participate in a panel discussion on RNAi Therapeutics at the Rodman & Renshaw conference taking place Thursday, September 10, 2009 at 8:25 am ET.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

Contact Information